Quarterly report pursuant to Section 13 or 15(d)

Concentrations

v3.24.3
Concentrations
9 Months Ended
Sep. 30, 2024
Risks and Uncertainties [Abstract]  
Concentrations

NOTE 12—CONCENTRATIONS

Revenue from the Company’s products are as follows (dollars in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Laser systems

 

$

5,876

 

 

 

54.2

%

 

$

6,647

 

 

 

60.9

%

 

$

17,058

 

 

 

52.4

%

 

$

21,666

 

 

 

60.7

%

Consumables and other

 

 

3,717

 

 

 

34.2

%

 

 

2,908

 

 

 

26.6

%

 

 

11,021

 

 

 

33.9

%

 

 

10,058

 

 

 

28.2

%

Services

 

 

1,257

 

 

 

11.6

%

 

 

1,366

 

 

 

12.5

%

 

 

4,457

 

 

 

13.7

%

 

 

3,950

 

 

 

11.1

%

Net revenue

 

$

10,850

 

 

 

100.0

%

 

$

10,921

 

 

 

100.0

%

 

$

32,536

 

 

 

100.0

%

 

$

35,674

 

 

 

100.0

%

 

No individual customer represented more than 10% of the Company’s revenue for the three and nine months ended September 30, 2024 or 2023.

The Company maintains its cash and cash equivalents in money market investment accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

As of September 30, 2024, no individual customer represented more than 10% of the Company's accounts receivable. As of December 31, 2023 accounts receivable from one customer totaled approximately 11% of total gross accounts receivable which has been partially received in 2024 and partially reserved for uncollectibility as of September 30, 2024.

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s business, results of operations and financial condition.